UBS Group AG Buys 294,695 Shares of Anteris Technologies Global Corp. $AVR

UBS Group AG grew its stake in Anteris Technologies Global Corp. (NASDAQ:AVR) by 133.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 515,725 shares of the company’s stock after purchasing an additional 294,695 shares during the period. UBS Group AG owned approximately 1.25% of Anteris Technologies Global worth $2,573,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of the stock. JPMorgan Chase & Co. grew its position in Anteris Technologies Global by 32.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,417,627 shares of the company’s stock worth $6,379,000 after acquiring an additional 349,299 shares during the last quarter. Russell Investments Group Ltd. grew its position in Anteris Technologies Global by 76.9% during the 3rd quarter. Russell Investments Group Ltd. now owns 6,536 shares of the company’s stock worth $29,000 after acquiring an additional 2,841 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in Anteris Technologies Global during the 1st quarter worth approximately $32,000. BNP Paribas Financial Markets grew its position in Anteris Technologies Global by 83.3% during the 3rd quarter. BNP Paribas Financial Markets now owns 9,469 shares of the company’s stock worth $43,000 after acquiring an additional 4,302 shares during the last quarter. Finally, Bank of America Corp DE grew its position in Anteris Technologies Global by 35.7% during the 3rd quarter. Bank of America Corp DE now owns 10,631 shares of the company’s stock worth $48,000 after acquiring an additional 2,798 shares during the last quarter.

Anteris Technologies Global Stock Performance

NASDAQ:AVR opened at $9.08 on Wednesday. The stock’s fifty day moving average price is $6.29 and its two-hundred day moving average price is $5.58. Anteris Technologies Global Corp. has a 52-week low of $2.85 and a 52-week high of $9.79. The company has a market cap of $883.85 million, a price-to-earnings ratio of -4.07 and a beta of 1.32.

Anteris Technologies Global (NASDAQ:AVR) last posted its quarterly earnings data on Tuesday, May 12th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by ($0.01). Anteris Technologies Global had a negative return on equity of 124.76% and a negative net margin of 5,148.78%.The firm had revenue of $0.49 million for the quarter, compared to analyst estimates of $0.77 million. During the same period in the prior year, the company posted ($0.61) EPS. On average, equities analysts predict that Anteris Technologies Global Corp. will post -1.14 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms recently commented on AVR. Cantor Fitzgerald restated an “overweight” rating and set a $15.00 price target on shares of Anteris Technologies Global in a research report on Friday, March 27th. Wall Street Zen upgraded Anteris Technologies Global from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. Wells Fargo & Company began coverage on Anteris Technologies Global in a research report on Wednesday, March 11th. They set an “overweight” rating and a $16.00 price target on the stock. Finally, Barclays increased their price target on Anteris Technologies Global from $17.00 to $18.00 and gave the stock an “overweight” rating in a research report on Friday, May 15th. Four analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $16.00.

Anteris Technologies Global Company Profile

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.